Publication date: Sep. 2024
There is no single "best" place, as it depends on the individual situation. Consulting with your local healthcare provider is recommended to determine the most appropriate option. For international patients seeking cost-effective treatment with good outcomes, Israeli hospitals appear to be a strong option to consider.
Several top options for receiving CAR-T cell therapy:
- United States:
• The US has the most FDA-approved CAR-T therapies available.
• Major cancer centers like Mayo Clinic offer comprehensive CAR-T programs with expertise and good outcomes.
• However, costs can be very high, around $475,000 or more. - Israel:
• Israeli hospitals offer excellent CAR-T programs with success rates comparable to those reported in the literature.
• Two hospitals (Sheba Hospital and Hadassah Hospital) offer in-house CAR-T therapies at significantly lower costs ($80,000-$150,000) as part of clinical trials.
• Israel is noted as providing some of the most cost-effective options.
- Other countries:
• Canada, Germany, France, Spain, UK, Italy, Australia, Singapore, and China also offer FDA-approved CAR-T therapies.
Key factors in choosing the best place:
- Availability in your home country
- Individual patient needs and circumstances
- Cost considerations
- Expertise and outcomes of the specific hospital/center
- Waiting times
- Availability of clinical trials for newer CAR-T approaches
